Axcelis Technologies, Inc. (ACLS)
NASDAQ: ACLS · Real-Time Price · USD
109.27
-1.10 (-1.00%)
Apr 13, 2026, 12:01 PM EDT - Market open
Company Description
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.
The company provides high energy, high current, and medium current implanters for various application requirements.
It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training.
The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force.
Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.
Axcelis Technologies, Inc.
| Country | United States |
| Founded | 1995 |
| IPO Date | Jul 11, 2000 |
| Industry | Semiconductor Equipment & Materials |
| Sector | Technology |
| Employees | 1,465 |
| CEO | Russell Low |
Contact Details
Address: 108 Cherry Hill Drive Beverly, Massachusetts 01915-1088 United States | |
| Phone | 978 787 4000 |
| Website | axcelis.com |
Stock Details
| Ticker Symbol | ACLS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001113232 |
| CUSIP Number | 054540208 |
| ISIN Number | US0545402085 |
| Employer ID | 34-1818596 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| Dr. Russell J. Low Ph.D. | Chief Executive Officer, President and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2026 | 144 | Filing |
| Mar 31, 2026 | ARS | Filing |
| Mar 31, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 24, 2026 | 144 | Filing |
| Mar 12, 2026 | 8-K | Current Report |
| Feb 26, 2026 | 10-K | Annual Report |
| Feb 20, 2026 | 144 | Filing |
| Feb 17, 2026 | 8-K | Current Report |
| Feb 12, 2026 | SCHEDULE 13G | Filing |